Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 385
Aptamer sequence: UACGACACGAUUGGGACGUGUCUAUGGGAC
Target unique ID: P27958
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_379 G9-Ⅲ Protein POLG_HCV77 8.9 nM 50 mM Tris/HCl (pH 7.8), 30 mM NaCl, 5 mM CaCl2 and 10 mM dithiothreitol 10848986
Structure information of aptamer
Aptamer Sequence: UACGACACGAUUGGGACGUGUCUAUGGGAC
The optimal secondary structure in dot-bracket notation: ...((((((.......))))))........
The centroid secondary structure in dot-bracket notation: ...((((((.......))))))........
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_379 Description G9-Ⅲ
Aptamer chemistry RNA Length 30 nt
GC content 53.3% Molecular weight 9,668.78 Da
Molarity of 1 μg/μl solution 103.43 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted binding
Sequence UACGACACGAUUGGGACGUGUCUAUGGGAC
Applications Selected aptamers have potential as anti-HCV compounds
Target information
Type Detail Type Detail
Uniprot ID P27958 Protein name Genome polyprotein [Cleaved into: Core protein precursor (Capsid protein C) (p23); Mature core protein (p21); Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); Viroporin p7; Protease NS2 (p23) (EC 3.4.22.-) (Non-structural protein 2) (NS2); Serine protease/helicase NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3 helicase) (NS3 protease) (NS3P) (Viroporin p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56/58); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
Gene name(s) N/A Organism Genome polyprotein [Cleaved into: Core protein precursor (Capsid protein C) (p23); Mature core protein (p21); Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); Viroporin p7; Protease NS2 (p23) (EC 3.4.22.-) (Non-structural protein 2) (NS2); Serine protease/helicase NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3 helicase) (NS3 protease) (NS3P) (Viroporin p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56/58); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
Status reviewed in uniprot database Length 3011
Mass 327,146 Activity regulation Inhibited by the antiviral drug hexamethylene amiloride (By similarity)
Involvement in disease N/A Catalytic activity Reaction=Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1
PDB ID(s)
1A1R;1A1V;1CWX;1HEI;1JR6;1N1L;1ONB;1R7C;1R7D;1R7E;1R7F;1R7G;1RGQ;2A4R;2F9V;2HD0;2JXF;2KDR;2N1P;2O8M;2OBO;2OBQ;2OC0;2OC1;2OC7;2OC8;2OIN;2P59;2QV1;2XI2;2XI3;2XNI;3RC4;3RC5;4CL1;4JZN;4JZO;4MWF;4N0Y;4Q0X;4XVJ;4Z0X;5EOC;5ERW;5FGB;5FGC;5JZI;5YXN;5YXU;6BQJ;6BQK;6BZU;6BZV;6BZW;6BZY;6UYD;6WO5;6WOQ;
Function Packages viral RNA to form a viral nucleocapsid, and promotes virion budding (Probable).
Activity data
Interaction ID 385
Target type Protein
Target unique ID P27958
Activity 8.9 nM
Binding Conditions/Buffer

50 mM Tris/HCl (pH 7.8), 30 mM NaCl, 5 mM CaCl2 and 10 mM dithiothreitol

Assay

Binding curves of selected RNA aptamers and DNS3. Data points were obtained by filter binding assay (50 mL reaction) as described in Materials and methods (G9-I, circle; G9-II, cross; and G9-III, square). The concentration of labeled aptamers was 5 nm

PubMed ID 10848986
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_378 RNA UGCUCUUAGAAUGGGACUAAGACACGGGAC 56.67%
Apta_926 RNA UCGGCAGCGGUUAGAGAGGUGGUGUGCGGG 56.67%
Apta_927 RNA UUACAAUGAGGUGGGACGCGGGUUGUGGUG 56.67%
Apta_1166 RNA GAUGUAACUGAAUGAAAUGGUGAAGGACGGGUCCAGUAGGCUGC 52.27%
Apta_152 RNA UUACCACGCGCUCUUAACUGCUAGCGCCAUGGC 51.52%
Apta_87 RNA UACCGACUAGCAAAACCUGCUGGCGACGUUUAGAU 51.43%
Apta_90 RNA ACAACCUAAAUGCGACGUUGGGUCAAAAACGUGAA 51.43%
Apta_92 RNA ACAACUUAAUGCGACGUUGGUAAAGCAUAUCAAAC 51.43%
Apta_94 RNA AUGACAGGAUGCAGAGCUCCACUGUCUAGUGUUUA 51.43%
Apta_230 RNA GGGAGGACGAUGCGGGCGUGAAUGGUGUUGUGAGG 51.43%
Apta_136 RNA CGUGUCGUCCUGGUACGAUUUGGUAUAUAACCGUGGCUUUUCGACA 50.00%
Apta_172 RNA GGAGACAUCCCUCUUGUUGGUGGUGCCGUGUGGAUGUCUC 50.00%
Apta_212 RNA AGGAAGGCUUUAGGUCUGAGAUCUCGGAAU 50.00%
Apta_231 RNA GGGAGGACGAUGCGGGUGUGGGGCG 50.00%
Apta_377 RNA CUUCGGGAUUUGAGGGUAGAAUGGGACUA 50.00%
Apta_703 RNA GGGCGGAUGAGACGCUUGGCGUGUGCUGUGGAGAGUCAUCCG 50.00%
Apta_960 DNA CCCGAGGCACGAGGGGGAACGTATCGTCATGTGCCGGCCA 50.00%
Apta_1167 RNA GGCGCGAGGAAGGAGGUCUGAGGAGGUCACUGCGCC 50.00%
Apta_1194 DNA GGGAGAGGTGGGAGCGGGGCCAGGG 50.00%
Apta_237 RNA UUCAACGCUGUGAAGGGCUUAUACGAGCGGAUUACCC 48.65%